8-K//Current report
Trillium Therapeutics Inc. 8-K
Accession 0001104659-21-140375
CIK 0001616212operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:28 AM ET
Size
246.5 KB
Accession
0001104659-21-140375
Documents
- 8-Ktm2133223d1_8k.htmPrimary
FORM 8-K
- EX-99.1tm2133223d1_ex99-1.htm
EXHIBIT 99.1
- EX-101.SCHtril-20211117.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABtril-20211117_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREtril-20211117_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- GRAPHICtm2133223d1_ex99-1img001.jpg
GRAPHIC
- XMLtm2133223d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-21-140375-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001616212
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 9:28 AM ET
- Size
- 246.5 KB